chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She also mentioned she experienced extreme fatigue with the 1st dose; she slept a lot after the administration of the 1st dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Feb2021 16:30 (Lot number: EN6200) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "She also mentioned she experienced extreme fatigue with the 1st dose"; SOMNOLENCE (non-serious), outcome "unknown", described as "she slept a lot after the administration of the 1st dose.".  Additional Information: Concomitant drugs: birth control pills. Prior vaccinations: None.  No follow-up attempts are possible. No further information is expected.
On day following vax, mom noted inject site on rt thigh to be hard, red, & sl warm; Hard palpable area 2 x 4 cm; seen & clinic; advised warm moist packs today & APAP for pain or fever; t99.2  ax;
Soreness near injection site; muscle soreness and stiffness in upper arm (injection site); skin discoloration at injection site; skin rash developed 2 days later, persisting for 9 days.  Treated with OTC topical meds.
Case number PHEH2016US029298, is an initial spontaneous report received from a nurse on 07 Nov 2016. This report refers to a 77 years old male patient. Past medical history and concomitant medications were not reported. The nurse stated that first temperature excursion of FLUCELVAX QUADRIVALENT at 52F for 1 hour occurred on 18 Oct 2016. The patient was vaccinated with FLUCELVAX QUADRIVALENT (batch number: not reported) at a dose of 0.5 ml intramuscularly on 20 Oct 2016. Second temperature excursion occurred on 23 Oct 2016, dropped low 06 times to 34F and lasted 30 minutes each time. Third temperature excursion occurred on 02 Nov 2016, down to 32.2F three times over the course of 12 hours. Vaccine had been administered. It was unknown if vaccine was frozen. Nurse did not know which lot was given to which patient. No adverse event was reported following this administration error (incorrect product storage).
Per records, patient was in 5 mile run and passed out--HR>180s and T~102.9 - adenosine and cardioversion with IVF-admitted to ICU-placed on broad spectrum Abx and Cx drawn. Progressive, rhabdomyolysis, DIC, renal failure, pain, and encephalopthy. Tx with cryo, ffp, fluids, pressors and ultimately transferred to another facility.
I have had mild tinnitus for many years, but about three weeks following administration of Covid 19 vaccine, it seems to me that the tinnitus worsened' it is now twice as loud as it was prior to vaccination with Covid 19. It is present at this volume daily. Though I have inquired with various providers, seems there's no treatment. Also, not sure, but I have neuropathy in my fingers (from Diabetes?) which seems to have worsened at about the same time.. I have been getting it treated at a chiropractic office and still working on getting alternative treatment.
Pt reports that she developed cellulitis at the site of the injection. This required treatment by her private MD with antibiotics.
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a 74 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-NOV-2021, the patient experienced covid-19 test positive. Laboratory data included: COVID-19 virus test (not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious. This case, from the same reporter is linked to 20211247645.
28 4/7 weeks premature infant was given vaccines on 10/23/00 at approximately 9:00. At 12:00 the infant had signs of decreased profusion, shock, malaise, acidosis, and cardiac arrest. Autopsy shows lung congestion. Death stated as caused by repiratory failure secondary to congenital heart failure.
Internal head pressure without pain, trouble focusing, and foggy headedness that lasted about 5 days.
41-year-old male with no previous medical history presenting emergency department complaining of right-sided rib and arm pain X 1 day. Per patient, he just had his second booster shot of the Moderna vaccine, since he has been experiencing symptoms. Symptoms described as moderate in nature, better with nothing, worse with movement and touch.  No history of the same. At this time he denies any recent injury or rash to area.
2 weeks after immunization patient developed thrombocytopenia (low platelet count), Bruising, Petechiae. Patient was referred to PCH ER / Heme Onc.
Pt developed a temperature to 101.8F (rectally) on 11/8/01.
The day after vaccine administered returned to our office with c/o vomiting that started the night after pt was vaccinated (same day). Vomiting continued to the day of presentation. Also with tactile fever and achiness. Recommended Tylenol.
The employee reports that she began with diarrhea, cough, tight chest and with a SoP2 of 95, she arrived at the Hospital, they measured her vital signs and the saturation had dropped to 94, she isolates her, they perform a chest x-ray. The doctor read the x-ray tells him that he has a swollen left ganglion and that he is about to have pneumonia.
Patient experienced nausea. consulted with NPdid vitals o2 98% hr 94 hx of afib bp 146/91; patient   was feeling fine stayed 30 minutes had caregiver with her to drive home
About 5 minutes after I received the shot, had a sudden burning sensation in the middle of my chest that radiated out. I thought that was it for me. Nausea, dizziness, numbness in my left cheek and arm, got a funny taste in my mouth. This got pretty intense and lasted about 10 minutes. They had me stay in observation for another 45 minutes as those symptoms came in waves but never as intense as the first time. They let me go and I went home to rest. On the way home my cheeks became flushed and it felt like my eyes and cheeks were swelling. I had a lot of other symptoms over the next several hours which I wrote down. Early Tuesday morning those symptoms went away and I was left with some flu like symptoms, dizziness and a brain fog like I have never had before.
Large bruise on left upper arm-became black and blue almost immediately.  Approximately 10 inch long width of his biceps.  has had previous flu shots, never bruising.  Felt "wierd" on and off for 30 days after getting shot.  Due to the circumstances of vaccination that generated this VAERS report, the vaccine manufacturer, the lot number, the injection site and the providers name and phone number were not available to us.
Shortness of breath; Anxious; Chest Heaviness; This is a Spontaneous report from a contactable pharmacist. A 41-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1284) via intramuscular route of administration on left arm at a single dose for COVID-19 immunization at a nursing home. The patient had no relevant medical history and no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks, or any other medications within 2 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced shortness of breath, anxious, and chest heaviness on 07Jan2021 11:00. The events were reported as non-serious but resulted in visit to the Emergency room/department or urgent care. Treatment and outcome of the events were unknown. The patient had not been tested for COVID-19 since the vaccination.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB, lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9, lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 11-year-old patient of unknown gender. On 12-JUN-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9, lot number N020352 (expiration date 10-APR-2020). This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
Information has been received from a nurse concerning a 20 year old female with a penicillin allergy, drug hypersensitivity to cefaclor (CECLOR) and no other pertinent medical history reported.  On 15-AUG-2006, the patient was vaccinated intramuscularly with HPV rLi 6 11 16 18 VLP vaccine (yeast) (Lot#653650/0702F).  Concomitant therapy included paroxetine HCL (PAXIL), bupropion HCL (WELLBUTRIN) and famotidine.  It was reported that the patient became faint within 5 minutes of vaccination with HPV rLi 6 11 16 18 VLP vaccine (yeast).  The patient was given a soda to drink as treatment.  There were no laboratory diagnostic studies performed.  On 15-AUG-2006, the patient recovered from the event.  Additional information has been requested.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (Headache). On 03-Feb-2021, HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    Reporter did not allow further contact
20 minutes after receiving the vaccine, my face felt very hot (but I thought this was because I was wearing a mask and in a large room that was stuffy with a lot of people). I left the facility 10 minutes later and in the car my face felt like it was on fire. When I arrived home, my husband noted that my face was very red. I also developed itching around where my clothes were tight (bra and underwear line). I looked in the mirror and my face was erythematous with a sandpaper like rash (similar to scarlatina). I did not develop a rash in the other areas I was itchy. I took Benadryl 50 mg. The symptoms did not worsen and improved some. Since that time, my face has continued to have a rough, sandpaper like feel and is pink. Yesterday evening it became red again and I took another dose of Benadryl 50 mg. Of note, I was told by 2 different providers to go to an Urgent Care yesterday, but I did not as my symptoms are only cutaneous.
ANGIOEDEMA, INIT 3/26/2023 BMI 45-49.9 ADULT ANGIOEDEMA, SEQUELA 4/3/2023 BMI 45-49.9 ADULT
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated an expired dose of ZOSTAVAX lot # (67061/0618AA, expiration date 26-JUL-2012) (dose and route not reported) on 01-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse event was reported. Additional information has been requested. This is one of several reports from the same source.
I'm feeling very poorly, shaking so bad; I'm feeling very poorly, shaking so bad; The pain was so bad in my feet last night that I couldn't walk; The pain was so bad in my feet last night that I couldn't walk; I think I'm dehydrated because my pulse is around 100; temperature was 100, went to 102; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I'm feeling very poorly, shaking so bad), TREMOR (I'm feeling very poorly, shaking so bad), PAIN IN EXTREMITY (The pain was so bad in my feet last night that I couldn't walk), GAIT DISTURBANCE (The pain was so bad in my feet last night that I couldn't walk) and DEHYDRATION (I think I'm dehydrated because my pulse is around 100) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028E2119) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Brain tumor. Concomitant products included GABAPENTIN, ATENOLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), FLUTICASONE PROPIONATE (FLOVENT) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 29-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced FEELING ABNORMAL (I'm feeling very poorly, shaking so bad), TREMOR (I'm feeling very poorly, shaking so bad), PAIN IN EXTREMITY (The pain was so bad in my feet last night that I couldn't walk), GAIT DISTURBANCE (The pain was so bad in my feet last night that I couldn't walk), DEHYDRATION (I think I'm dehydrated because my pulse is around 100) and PYREXIA (temperature was 100, went to 102). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (I'm feeling very poorly, shaking so bad), TREMOR (I'm feeling very poorly, shaking so bad), PAIN IN EXTREMITY (The pain was so bad in my feet last night that I couldn't walk), GAIT DISTURBANCE (The pain was so bad in my feet last night that I couldn't walk), DEHYDRATION (I think I'm dehydrated because my pulse is around 100) and PYREXIA (temperature was 100, went to 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: (High) temperature was 100, went to 102. On an unknown date, Heart rate: (High) Pulse rate was around 100.         Reportedly,Patient took third dose of the vaccine with LOT 028E2119 or 088E2119.   This case was linked to MOD-2021-037906, MOD-2021-036365 (Patient Link).
It was discovered on 01/24/2023 that our ProQuad vaccine had been stored in the fridge and not the freezer.  Patient was given a dose of ProQuad that had been stored improperly.  Patient has not reported any adverse reactions from the initial vaccine, but will be brought into clinic to be revaccinated.
pretty severe pain in his shoulder and neck; it is not just at the injection site; pretty severe pain in his shoulder and neck; This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (pretty severe pain in his shoulder and neck), VACCINATION SITE PAIN (it is not just at the injection site) and ARTHRALGIA (pretty severe pain in his shoulder and neck) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (pretty severe pain in his shoulder and neck), VACCINATION SITE PAIN (it is not just at the injection site) and ARTHRALGIA (pretty severe pain in his shoulder and neck). At the time of the report, NECK PAIN (pretty severe pain in his shoulder and neck), VACCINATION SITE PAIN (it is not just at the injection site) and ARTHRALGIA (pretty severe pain in his shoulder and neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.  Patient stated events occurred 2 days after vaccination.
Vomited; throat/tongue swelled up really badly; throat/tongue swelled up really badly; feel kind of sick; Initial information received on 22-Sep-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-healthcare professional.  This case involves Adult female patient who experienced vomited, throat/tongue swelled up really badly, and feel kind of sick after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer formulation, strength, dose, expiry date, lot number not reported via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient developed vomited (vomiting), throat/tongue swelled up really badly (pharyngeal swelling) (swollen tongue) and feel kind of sick (illness) (unknown latency) following the administration of Influenza Vaccine.  Reportedly, Patient says that for the 4th or 5th time, the side of their throat/tongue swelled up really badly, consulted their doctor who instructed them to take Benadryl the night before, the day of, and the day after shot; this past time they forgot to take their Benadryl this past dose and they vomited - thinks it's the 2nd time to have happened, thinks it might be from getting their flu shot - feel kind of sick after getting the flu shot.  Action taken was not applicable.  The patient was treated with diphenhydramine hydrochloride (Benadryl [Diphenhydramine Hydrochloride]) for Adverse events.  At time of reporting, the outcome was Unknown for the events.; Sender's Comments:  US-SA-2023SA293607:split case
5 minutes after while seated in waiting area, I slowly became dizzy, started to lose sight and hearing. I alerted a nurse, who took held my head and helped me regulate breathing as I started to pass out. She held an ice pack to my neck and got me water.  She and another nurse tried to move towards an open door for fresh air and wanted to lay me down on a gurney, but I couldn't stand so they carried me to a wheelchair, where I stayed for about 35 minutes more until I had recovered. I don't think I fully lost consciousness, but almost completely lost sight and hearing. I was not consciously anxious about getting the vaccine or needles.
Patient discharged from vaccine event asymptomatic at 1645, returned to work, then came back to vaccine tent at 1800 stating she had a "splitting headache, was cold, clammy and nauseated."  Vital signs SPO2 99% HR 72 and regular, Blood pressure 148/98, skin dry, hands cool, at this time denying nausea, still with complaints of headache.  At 1830 HR 75 regular heart rate remains regular, SPOS 99%, denies any airway issues, declined water or crackers, wanted to go home.
Injection site soreness; Fatigue; Mild headache; This is a spontaneous report from a non-contactable pharmacist. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of the vaccination and other vaccines within four weeks prior to the COVID vaccine. On 02Apr2021, the patient experienced injection site soreness, fatigue and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site soreness, fatigue and mild headache were resolving at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Day  off: body crash, joint pain. 1 week later: skin reaction -  quarter  sized bruise  around injection site surrounding dime sized sore with scabbing. Note: injection was  uneventful at time (no pain or otherissues)
Next day repeated sneezing all day every 5 minutes 2 sneezes; This is a spontaneous report from a contactable consumer  (the patient).  A non-pregnant 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration, in the right arm on 05Feb2021 at 10:00 AM (at the age of 62-years) as a single dose for COVID-19 immunization. Medical history included diabetes mellitus.  The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included liraglutide (VICTOZA), metformin, lisinopril, bupropion hydrochloride (WELLBUTRIN), rosuvastatin calcium (COLESTRAX). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Feb2021, the next day after vaccination, at 2:30 PM, the patient had repeated sneezing all day every 5 minutes 2 sneezes. No treatment was given. The clinical outcome of the sneezing was not recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Pt devel inj site rxn of small area of erythema p/vax. July1, a 10-20 mm nodule was detected @ inj site. Nodule was painful.
Throat swelling. Improved with Benadryl. Recurred. Improved with famotodine, Benadryl and decadron